Although we do not currently know the genes downstream from FOXA1 which regulate multidrug resistance, our data clearly supports a role of FOXA1 in the regulation of genes controlling response to doxorubicin and paclitaxel in breast cancer cell models. Here, FOXA1 is linked to breast carcinoma.